10:51 AM EDT, 10/29/2024 (MT Newswires) -- Skye Bioscience ( SKYE ) said Tuesday that it has appointed independent director Paul Grayson as its new chairman effective Oct. 25.

Grayson succeeds Punit Dhillon, who will remain as Skye's chief executive officer and as a board member, the company added. Grayson currently serves as chief executive officer of Radionetics Oncology.

Skye Bioscience ( SKYE ) shares were down more than 3% in Tuesday trading.

Price: 4.97, Change: -0.19, Percent Change: -3.59